$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Can I live a normal lifespan by taking Biktarvy?
2026-02-01 22:25:32
Check Details
The efficacy and role of tremelimumab
2026-02-01 22:25:32
Check Details
Instructions for Biktarvy tablets
2026-02-01 22:25:32
Check Details
Domestic price of tremelimumab
2026-02-01 22:25:32
Check Details
What should I do if I become resistant to tremelimumab?
2026-02-01 22:25:32
Check Details
How many years does tremelimumab usually last?
2026-02-01 22:25:32
Check Details
How tremelimumab works
2026-02-01 22:25:32
Check Details
Is tremelimumab an immunosuppressant?
2026-02-01 22:25:32
Check Details
Can pregnant women use tremelimumab?
2026-02-01 22:25:32
Check Details
Can it be completely cured by taking tremelimumab?
2026-02-01 22:25:32
Check Details
The difference between tremelimumab and tremelimumab
2026-02-01 22:25:32
Check Details
Can tremelimumab be used in combination?
2026-02-01 22:25:32
Check Details
1
2
...
34
35
36
37
38
39
40
...
10220
10221
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Idelalisib: Oral PI3Kδ Inhibitor for Relapsed/Refractory Hematologic Malignancies
2
Lorlatinib (Lorviqua): Oral Targeted Therapy for ALK-Positive Advanced Non-Small Cell Lung Cancer
3
Elafibranor for Primary Biliary Cholangitis: Indication, Dosing, and Safety Overview
4
AbbVie’s TEPKINLY (epcoritamab) Plus R² Granted EU Approval for Relapsed/Refractory Follicular Lymphoma
5
FDA Approves Ibrance for New Maintenance Indication in HR+/HER2+ Breast Cancer
6
FDA Approves Trodelvy for Two First-Line Indications, Redefining Advanced Triple-Negative Breast Cancer Care
7
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice
8
Managing Amivantamab Infusion Reactions: A Clinical Guide for International Practice
9
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
10
Lusutrombopag: An Oral Pre-procedural Option for Thrombocytopenia in Chronic Liver Disease
11
Pretomanid Medication Guide: Core Agent in the BPaL Regimen for Drug-Resistant Tuberculosis
12
Can Fezolinetant Treat Depression? A Comprehensive Analysis of Menopause Medication and Mood